Recent VYGR News
- Voyager Reports Third Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 11/12/2024 09:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 09:00:21 PM
- Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 11/06/2024 12:00:00 PM
- Voyager Therapeutics Announces Third Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 11/05/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2024 08:43:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/02/2024 08:26:51 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/02/2024 08:09:19 PM
- Voyager Advances Collaboration with Neurocrine; Third Gene Therapy Development Candidate Selected • GlobeNewswire Inc. • 09/16/2024 11:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/05/2024 12:06:12 PM
- Voyager Enters into License for Next-Generation Capsid, Bringing Partnered Portfolio of TRACER-Enabled Gene Therapies to 14 • GlobeNewswire Inc. • 09/05/2024 12:00:00 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 08/29/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Upcoming Investor Conferences • GlobeNewswire Inc. • 08/29/2024 11:00:00 AM
- Voyager Therapeutics to Present at Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase • GlobeNewswire Inc. • 08/07/2024 11:00:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 08/06/2024 08:11:30 PM
- Voyager Therapeutics Reports Second Quarter 2024 Financial and Operating Results • GlobeNewswire Inc. • 08/06/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:00:13 PM
- Voyager Therapeutics Announces Second Quarter 2024 Conference Call and Webcast • GlobeNewswire Inc. • 07/30/2024 11:00:00 AM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/23/2024 08:01:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:11:23 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 07/09/2024 08:10:34 PM
- Voyager Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • GlobeNewswire Inc. • 07/09/2024 08:01:00 PM
- Voyager Therapeutics to Present at Multiple Virtual Investor Conferences • GlobeNewswire Inc. • 06/13/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 11:06:00 AM
- Voyager Therapeutics Announces Appointment of Nathan Jorgensen as Chief Financial Officer • GlobeNewswire Inc. • 06/13/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:22:47 PM
Kona Gold Beverage, Inc. Updates Multi-Million Dollar Merger and Posts Over $1.2 Million in Q3 Revenues • KGKG • Nov 15, 2024 10:36 AM
HealthLynked Corp. Announces Third Quarter and Year-to-Date 2024 Results with Strategic Restructuring, Third-Party Debt Repayment, and Core Technology Focus • HLYK • Nov 15, 2024 8:00 AM
Alliance Creative Group (ACGX) Releases Q3 2024 Financial and Disclosure Report with an increase of over 100% in Net Income for 1st 9 months of 2024 vs 2023 • ACGX • Nov 14, 2024 8:30 AM
Unitronix Corp. Publishes Its Cryptocurrency Portfolio Strategy • UTRX • Nov 14, 2024 8:05 AM
Avant Technologies and Ainnova Tech Form Joint Venture to Advance Early Disease Detection Using Artificial Intelligence • AVAI • Nov 12, 2024 9:00 AM
Swifty Global Announces Launch of Swifty Sports IE, Expanding Sports Betting and Casino Services in the Irish Market • DRCR • Nov 12, 2024 9:00 AM